Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
141 hedge funds and large institutions have $691M invested in Infinity Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 29 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 29
37% more call options, than puts
Call options by funds: $6.98M | Put options by funds: $5.1M
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
1% less funds holding
Funds holding: 143 → 141 (-2)
11% less capital invested
Capital invested by funds: $779M → $691M (-$87.3M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$16.3M |
| 3 |
Goldman Sachs
New York
|
+$13.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.49M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.9M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.6M |
| 3 |
BC
Broadfin Capital
New York
|
-$7.6M |
| 4 |
O
OrbiMed
New York
|
-$7.22M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.97M |
INFI Hedge Fund Activity: Q1 2015 in Review
141 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2015, worth a combined $691M — down 11% from $779M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of INFI and 28 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 58 added.
The largest buyer was Vanguard Group, adding an estimated $20.5M. The largest seller was Fidelity Investments, cutting an estimated $12.9M.
- 141 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2015, down from 143 in Q4 2014.
- Funds reported $691M of Infinity Pharmaceuticals, Inc. stock for Q1 2015, down 11% quarter-over-quarter.
- 28 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2015 and 29 closed out, a net change of -1 holder.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2015 was Vanguard Group, an estimated $20.5M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q1 2015 was Fidelity Investments, an estimated $12.9M sold.
Based on aggregated 13F filings for Q1 2015.